ECL Stock Analysis — Ecolab
Sector: Industrials
AI Verdict
Ecolab trades at a premium that only makes sense if its high switching costs keep earnings growing at the forecast pace—otherwise, you’re paying up for safety and stability.
Competitive Moat
Ecolab dominates water, hygiene, and infection prevention services for industries like food, healthcare, and hospitality, leveraging decades of proprietary chemical formulations and deep customer integration. Its moat comes from high switching costs and regulatory expertise that make it hard for competitors to displace embedded solutions.
Summary
Ecolab stands out for its sticky B2B contracts in critical water and hygiene management, with forward earnings growth expected to accelerate.
Where It Stands
Ecolab has returned just 3.02% over the past year, trades at 30.3x next year's earnings (well above the industrials median of 20x), and its RSI of 64.4 signals shares are approaching overbought territory.
Key Metrics
- RSI: 64.4 — Near Overbought
- Trailing P/E: 38.3x
- Forward P/E: 30.3x
- PEG Ratio: 1.44
- Earnings Growth: +0.3%
- Revenue Growth: +0.0%
- Market Cap: $79.7B
- Dividend Yield: 0.01%
- 1-Year Return: 3.02%
- 52-Week High: $309.27
- 52-Week Low: $243.15
Analyst Consensus
23 Buy · 9 Hold · 0 Sell (32 analysts)
Bull Case
You’re paying 30.3x forward earnings for 26.6% expected EPS growth, which is a fair price if Ecolab’s customer lock-in keeps driving profit expansion.
Bear Case
If the P/E multiple falls to the sector median of 20x, the stock would lose about a third of its value from here, especially with an RSI of 64.4 suggesting pullback risk.
Catalyst to Watch
Watch for quarterly earnings surprises or large contract wins, as these could justify the premium multiple if they show sustained margin growth.